MDWDMediWound Ltd.

Nasdaq mediwound.com


$ 18.12 $ 0.37 (2.09 %)    

Monday, 16-Sep-2024 15:56:13 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 18.06
$ 17.83
$ 18.04 x 100
-- x --
$ 17.50 - $ 18.14
$ 7.45 - $ 24.00
32,197
na
166.55M
$ 1.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-mediwound-maintains-28-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price...

 mediwound-q2-adj-068-misses-042-estimate-sales-506m-inline

MediWound (NASDAQ:MDWD) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.44) b...

 mediwound-announces-results-from-next-protocol-for-nexobrid-in-burn-treatment

MediWound Ltd. (NASDAQ:MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair, today announced th...

 mediwound-announces-publication-of-the-escharex-phase-ii-chronex-study-results-for-venous-leg-ulcers-in-the-lancets-eclinicalmedicine

Research Published in THE LANCET's eClinicalMedicineEscharEx® Outperforms Non-Surgical Standard of Care in Debridement and ...

 hc-wainwright--co-reiterates-buy-on-mediwound-maintains-28-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price...

Core News & Articles

- SEC Filing

 mlnlycke-invests-15m-in-mediwound-to-enhance-wound-care-solutions

Mölnlycke Health Care, a world-leading MedTech company specialising in solutions for wound care and surgical procedures, announ...

 mediwound-announces-25m-strategic-private-placement-financing-of-145m-shares-at-1720share-to-advance-escharex-pre-commercial-activities

MediWound Ltd. (NASDAQ:MDWD), the world leader in next-generation enzymatic therapeutics for tissue repair, today announced it ...

 why-nio-shares-are-trading-lower-by-over-8-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of NIO Inc. (NYSE:NIO) fell sharply during Friday's session after the company disclosed that Steven Wei Feng has res...

 why-sharps-technology-shares-are-trading-higher-by-around-32-here-are-20-stocks-moving-premarket

Shares of Sharps Technology, Inc. (NASDAQ:STSS) rose sharply in today's pre-market trading after the company announced it r...

 hc-wainwright--co-reiterates-buy-on-mediwound-maintains-28-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price...

 mediwound-to-present-new-data-from-escharex-phase-ii-studies-at-3-wound-care-conferences

Oral presentations include additional comparative data between EscharEx® and SANTYL®, and new analyses show strong correlation ...

 hc-wainwright--co-reiterates-buy-on-mediwound-maintains-28-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price...

 mediwound-q4-eps-019-beats-023-estimate-sales-534m-beat-532m-estimate

MediWound (NASDAQ:MDWD) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.23) by ...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION